“bio-ceo-investor-conference” Archives

in
Entry Author Date Location
FDA’s Rachel Sherman on Right to Try, Succession Trouble & More 02/13/18 New York
Execs Talk Hurdles As Immunotherapy Combos, CAR-T Launches Progress 02/12/18 New York
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
His Gene Therapy Near Approval, Spark CEO Wonders: What Price Vision? 02/16/17 New York
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 02/11/16 New York
Gene Editing Execs Talk Scientific, Regulatory Hurdles At BIO Panel 02/10/16 Boston
Biogen’s Scangos on Pricing, Deals, Hemophilia, Alzheimer’s & More 02/09/16 Boston
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More 02/13/15 Boston
Gilead Exec: More Value in Quick Hep C Cure than Cancer Treatments 02/10/15 San Francisco
“21st Century Cures” By Year’s End? Its Backers Want More Ideas 02/09/15 National
The Show Must Go On: Invest Northwest Forges Ahead Despite Grim Biotech Climate 02/17/09 Seattle
Cell Therapeutics Teeters on the Brink as Cash Runs Out on Promising Cancer Drugs 02/13/09 Seattle
Page 1 of 1